Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

ProRx LLC recalls Tirzepatide Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Tirzepatide Injection
Company
ProRx LLC
Where it was sold

TX and UT

States: Texas, Utah

Units affected
2,761 vials
About this recall
Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03